Ahangari, S., Littrup Andersen, F., Liv Hansen, N., Jakobi Nøttrup, T., Berthelsen, A. K.
, Folsted Kallehauge, J., Richter Vogelius, I., Kjaer, A., Espe Hansen, A. & Fischer, B. M. (2022).
Multi-parametric PET/MRI for enhanced tumor characterization of patients with cervical cancer.
European Journal of Hybrid Imaging,
6(1), Article 7.
https://doi.org/10.1186/s41824-022-00129-2
Ahern, T. P., Spector, L. G., Damkier, P.
, Öztürk Esen, B., Ulrichsen, S. P., Eriksen, K., Lash, T. L., Sørensen, H. T. & Cronin-Fenton, D. P. (2022).
Medication-Associated Phthalate Exposure and Childhood Cancer Incidence.
Journal of the National Cancer Institute,
114(6), 885-894.
https://doi.org/10.1093/jnci/djac045
Ahle, C. M.
, Stødkilde, K., Poehlein, A., Bömeke, M., Streit, W. R., Wenck, H., Reuter, J. H., Hüpeden, J.
& Brüggemann, H. (2022).
Interference and co-existence of staphylococci and Cutibacterium acnes within the healthy human skin microbiome.
Communications Biology,
5(1), Article 923.
https://doi.org/10.1038/s42003-022-03897-6
Ahmed, I. A., Liu, J.-J., Gieniec, K. A., Bair-Marshall, C. J., Adewakun, A. B., Hetzler, B. E., Arp, C. J., Khatri, L.
, Vanwalleghem, G. C., Seidenberg, A. T., Cowin, P., Trauner, D., Chao, M. V.
, Davis, F. M., Tsien, R. W. & Froemke, R. C. (2022).
Optopharmacological tools for precise spatiotemporal control of oxytocin signaling in the central nervous system and periphery.
https://doi.org/10.1101/2022.11.10.516001
Ahmed, K. I., Lunenburg, C., Thirstrup, J. P., Clausen, L., Thomsen, P. H. & Gasse, C. (2022).
Pharmacogenetic CYP2D6 variabliity, phenoconversion and treatment outcomes: A Danish population-based cohort study in 6,798 individuals initiation atomoxetine treatment. Poster session presented at European Congress of Psychiatry, Budapest, Hungary.
Ahmed, K. I., Lunenburg, C., Thirstrup, J. P., Clausen, L., Thomsen, P. H. & Gasse, C. (2022).
Pharmacogenetic CYP2D6 variabliity, phenoconversion and treatment outcomes: A Danish population-based cohort study in 6,798 individuals initiation atomoxetine treatment. European Congress of Psychiatry.
European Psychiatry,
65(Special Issue S1), S227-S227.
https://doi.org/10.1192/j.eurpsy.2022.588
Ahrends, C., Stevner, A., Pervaiz, U.
, Kringelbach, M. L., Vuust, P., Woolrich, M. W.
& Vidaurre, D. (2022).
Data and model considerations for estimating time-varying functional connectivity in fMRI.
NeuroImage,
252, Article 119026.
https://doi.org/10.1016/j.neuroimage.2022.119026
Ahrenfeldt, J., Christensen, D. S., Sokač, M., Kisistók, J., McGranahan, N.
& Birkbak, N. J. (2022).
Computational Analysis Reveals the Temporal Acquisition of Pathway Alterations during the Evolution of Cancer.
Cancers,
14(23), Article 5817.
https://doi.org/10.3390/cancers14235817
Ahrens, L. C., Krabbenhoft, M. G., Hansen, R. W.
, Mikic, N., Pedersen, C. B., Poulsen, F. R.
& Korshoej, A. R. (2022).
Effect of 5-Aminolevulinic Acid and Sodium Fluorescein on the Extent of Resection in High-Grade Gliomas and Brain Metastasis.
Cancers,
14(3), Article 617.
https://doi.org/10.3390/cancers14030617
Ahring, K. K.
, Dagnæs-Hansen, F., Brüel, A., Christensen, M.
, Jensen, E., Jensen, T. G., Johannsen, M., Johansen, K. S., Lund, A. M.
, Madsen, J. G., Brøndum-Nielsen, K.
, Pedersen, M., Sørensen, L. K., Kjolby, M. & Møller, L. B. (2022).
The effect of casein glycomacropeptide versus free synthetic amino acids for early treatment of phenylketonuria in a mice model.
PLoS One,
17(1), Article e0261150.
https://doi.org/10.1371/journal.pone.0261150
Ajnakina, O., Shamsutdinova, D.
, Wimberley, T., Dalsgaard, S. & Steptoe, A. (2022).
High polygenic predisposition for ADHD and a greater risk of all-cause mortality: a large population-based longitudinal study.
BMC Medicine,
20, Article 62.
https://doi.org/10.1186/s12916-022-02279-3
Ajnakina, O., Murray, R.
, Wimberley, T., Dalsgaard, S. & Steptoe, A. (2022).
Mapping Relationships Between Polygenic Propensity for ADHD and Difficulties Across Multiple Life Domains in the General Population: Evidence from The English Longitudinal Study of Ageing.
European Neuropsychopharmacology,
63, e100.
https://doi.org/10.1016/j.euroneuro.2022.07.190
Akbari, M., West, J. D., Doerr, N., Kipp, K. R., Marhamati, N., Vuong, S., Wang, Y.
, Rinschen, M. M., Talbot, J. J., Wessely, O. & Weimbs, T. (2022).
Restoration of atypical protein kinase C ζ function in autosomal dominant polycystic kidney disease ameliorates disease progression.
Proceedings of the National Academy of Sciences (PNAS),
119(30), Article e2121267119.
https://doi.org/10.1073/pnas.2121267119
Aktaa, S., Abdin, A., Arbelo, E., Burri, H., Vernooy, K., Blomström-Lundqvist, C., Boriani, G., Defaye, P., Deharo, J.-C., Drossart, I., Foldager, D., Gold, M. R., Johansen, J. B., Leyva, F., Linde, C., Michowitz, Y.
, Kronborg, M. B., Slotwiner, D., Steen, T. ... Gale, C. P. (2022).
European Society of Cardiology Quality Indicators for the care and outcomes of cardiac pacing: developed by the Working Group for Cardiac Pacing Quality Indicators in collaboration with the European Heart Rhythm Association of the European Society of Cardiology.
EP Europace,
24(1), 165–172.
https://doi.org/10.1093/europace/euab193
Al-Absi, A.-R., Thambiappa, S. K., Khan, A. R.
, Glerup, S., Sanchez, C., Landau, A. M. & Nyengaard, J. R. (2022).
Df(h22q11)/+ mouse model exhibits reduced binding levels of GABAA receptors and structural and functional dysregulation in the inhibitory and excitatory networks of hippocampus.
Molecular and Cellular Neuroscience,
122, Article 103769.
https://doi.org/10.1016/j.mcn.2022.103769
Alam, P., Holst, M. R., Lauritsen, L.
, Nielsen, J., Nielsen, S. S. E., Jensen, P. H., Brewer, J. R.
, Otzen, D. E. & Nielsen, M. S. (2022).
Polarized α-synuclein trafficking and transcytosis across brain endothelial cells via Rab7-decorated carriers.
Fluids and Barriers of the CNS,
19(1), Article 37.
https://doi.org/10.1186/s12987-022-00334-y
Al-Bakri, M., Skovgaard, A. M., Bach-Holm, D.
, Larsen, D. A., Siersma, V. & Kessel, L. (2022).
Increased Incidence of Mental Disorders in Children with Cataract: Findings from a Population-based Study.
American Journal of Ophthalmology,
236, 204-211.
https://doi.org/10.1016/j.ajo.2021.09.034
Al-Bakri, M., Bach-Holm, D.
, Larsen, D. A., Siersma, V.
& Kessel, L. (2022).
Socio-economic status in families affected by childhood cataract.
Acta Ophthalmologica,
100(2), 183-188.
https://doi.org/10.1111/aos.14768
Albertsen, L. N.
, Jaensch, C., Tornbjerg, S. M.
, Theil, J. & Madsen, A. H. (2022).
Correlation between incidental focal colorectal FDG uptake on PET/CT and colonoscopic and histopathological results.
Scandinavian Journal of Gastroenterology,
57(2), 246-252.
https://doi.org/10.1080/00365521.2021.1998602
Albiges, L., Tannir, N. M., Burotto, M., McDermott, D., Plimack, E. R., Barthélémy, P., Porta, C., Powles, T.
, Donskov, F., George, S., Kollmannsberger, C. K., Gurney, H., Grimm, M. O., Tomita, Y., Castellano, D., Rini, B. I., Choueiri, T. K., Leung, D., Saggi, S. S. ... Motzer, R. J. (2022).
First-line Nivolumab plus Ipilimumab Versus Sunitinib in Patients Without Nephrectomy and With an Evaluable Primary Renal Tumor in the CheckMate 214 Trial.
European Urology,
81(3), 266-271.
https://doi.org/10.1016/j.eururo.2021.10.001
Albiñana, C., Boelt, S. G., Cohen, A. S.
, Zhu, Z., Musliner, K. L., Vilhjálmsson, B. J. & McGrath, J. J. (2022).
Developmental exposure to vitamin D deficiency and subsequent risk of schizophrenia.
Schizophrenia Research,
247, 26-32.
https://doi.org/10.1016/j.schres.2021.06.004
Albrechtsen, S. S., Riis, R. G. C., Amiri, M., Tanum, G., Bergdal, O., Blaabjerg, M.
, Simonsen, C. Z. & Kondziella, D. (2022).
Impact of MRI on decision-making in ICU patients with disorders of consciousness.
Behavioural Brain Research,
421, Article 113729.
https://doi.org/10.1016/j.bbr.2021.113729
Al-Hakem Falk, H.
, Andersen, M. S., Cviko, H.
, Dalby, R. B., Korshøj, A. R., Truong, K. M. T. L. & Hansen, M. R. H. (2022).
Cerebral absces er en svær diagnose: Ugens billede.
Ugeskrift for Læger,
184, Article V71144.
https://ugeskriftet.dk/videnskab/cerebral-absces-er-en-svaer-diagnose
Ali, Z., Egeberg, A., Thyssen, J. P., Sørensen, J. A.
, Vestergaard, C. & Thomsen, S. F. (2022).
No association between omalizumab use and risk of cancer: a nationwide registry-based cohort study.
British Journal of Dermatology,
186(4), 746-748.
https://doi.org/10.1111/bjd.20941
Allesøe, R. L., Nudel, R., Thompson, W. K., Wang, Y., Nordentoft, M.
, Børglum, A. D., Hougaard, D. M., Werge, T., Rasmussen, S. & Benros, M. E. (2022).
Deep learning-based integration of genetics with registry data for stratification of schizophrenia and depression.
Science Advances,
8(26), eabi7293. Article eabi7293.
https://doi.org/10.1126/sciadv.abi7293
Al-Mashhadi, Z. K., Viggers, R.
, Fuglsang-Nielsen, R., Vestergaard, P.
, Gregersen, S. & Starup-Linde, J. (2022).
Fracture risk in treatment with GLP-1RA compared to DPP-4i: a Danish nationwide cohort study.
Diabetologia,
65(SUPPL 1), S183.
Al-Mashhadi, Z., Viggers, R.
, Linde, J. S., Vestergaard, P.
& Gregersen, S. (2022).
SGLT2 inhibitor treatment does not increase risk of osteoporotic fractures compared to GLP-1 receptor agonists: a Danish population-based cohort study.
Endocrine Abstracts,
81, Article OC8.2.
https://doi.org/10.1530/endoabs.81.OC8.2
Al-Mashhadi, Z. K., Viggers, R.
, Starup-Linde, J., Vestergaard, P.
& Gregersen, S. (2022).
SGLT2 inhibitor treatment is not associated with an increased risk of osteoporotic fractures when compared to GLP-1 receptor agonists: A nationwide cohort study.
Frontiers in Endocrinology,
13, Article 861422.
https://doi.org/10.3389/fendo.2022.861422
Al-Mashhadi, Z. K., Viggers, R.
, Fuglsang-Nielsen, R., Vestergaard, P.
, Gregersen, S. & Starup-Linde, J. (2022).
The risk of major osteoporotic fractures with GLP-1 receptor agonists when compared to DPP-4 inhibitors: A Danish nationwide cohort study.
Frontiers in Endocrinology,
13, Article 882998.
https://doi.org/10.3389/fendo.2022.882998
Alrø, A. B., Nedergaard, H. K., Svenningsen, H., Jensen, H. I.
& Dreyer, P. (2022).
Patients’ experiences of cognitive impairment following critical illness: a scoping review protocol.
BMJ Open,
12(4), Article e056156.
https://doi.org/10.1136/bmjopen-2021-056156
Alsbjerg, B., Kesmodel, U. S., Elbaek, H. O., Laursen, R., Laursen, S. B., Andreasen, D.
, Povlsen, B. B. & Humaidan, P. (2022).
GnRH agonist supplementation in hormone replacement therapy-frozen embryo transfer cycles: a randomized controlled trial.
Reproductive BioMedicine Online,
44(2), 261-270.
https://doi.org/10.1016/j.rbmo.2021.10.019
Alsing, S., Doktor, T. K.
, Askou, A. L., Jensen, E. G., Ahmadov, U., Kristensen, L. S., Andresen, B. S.
, Aagaard, L. & Corydon, T. J. (2022).
VEGFA-targeting miR-agshRNAs combine efficacy with specificity and safety for retinal gene therapy.
Molecular Therapy - Nucleic Acids,
28, 58-76.
https://doi.org/10.1016/j.omtn.2022.02.019